These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32920141)

  • 1. Exploring efficacy of natural-derived acetylphenol scaffold inhibitors for α-glucosidase: Synthesis, in vitro and in vivo biochemical studies.
    Yu X; Zhang F; Liu T; Liu Z; Dong Q; Li D
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127528. PubMed ID: 32920141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzonate derivatives of acetophenone as potent α-glucosidase inhibitors: synthesis, structure-activity relationship and mechanism.
    Dan WJ; Zhang Q; Zhang F; Wang WW; Gao JM
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):937-945. PubMed ID: 31072245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies.
    Ihmaid S
    Molecules; 2018 May; 23(6):. PubMed ID: 29844263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyramine Derivatives as Potent Therapeutics for Type 2 Diabetes: Synthesis and
    Bashir MA; Javaid K; Shaikh M; Choudhary MI; Siddiqui H
    Med Chem; 2020; 16(8):1124-1135. PubMed ID: 32003674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.
    Nikookar H; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Ranjbar PR; Mahdavi M; Larijani B
    Bioorg Chem; 2018 Apr; 77():280-286. PubMed ID: 29421703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 2-acylbenzofuranes as novel α-glucosidase inhibitors with hypoglycemic activity.
    Spasov AA; Babkov DA; Prokhorova TY; Sturova EA; Muleeva DR; Demidov MR; Osipov DV; Osyanin VA; Klimochkin YN
    Chem Biol Drug Des; 2017 Dec; 90(6):1184-1189. PubMed ID: 28585419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
    Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
    Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
    Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P
    Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.
    Ye GJ; Lan T; Huang ZX; Cheng XN; Cai CY; Ding SM; Xie ML; Wang B
    Eur J Med Chem; 2019 Sep; 177():362-373. PubMed ID: 31158750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
    Azimi F; Ghasemi JB; Azizian H; Najafi M; Faramarzi MA; Saghaei L; Sadeghi-Aliabadi H; Larijani B; Hassanzadeh F; Mahdavi M
    Int J Biol Macromol; 2021 Jan; 166():1082-1095. PubMed ID: 33157144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonic synthesis of tyramine derivatives as novel inhibitors of α-glucosidase in vitro.
    Siddiqui H; Bashir MA; Javaid K; Nizamani A; Bano H; Yousuf S; Rahman AU; Choudhary MI
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1392-403. PubMed ID: 26912275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Mercapto Benzothiazole Derivatives: As Potential Leads for the Diabetic Management.
    Ullah S; Mirza S; Salar U; Hussain S; Javaid K; Khan KM; Khalil R; Atia-Tul-Wahab ; Ul-Haq Z; Perveen S; Choudhary MI
    Med Chem; 2020; 16(6):826-840. PubMed ID: 31195949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory mechanism of morin on α-glucosidase and its anti-glycation properties.
    Zeng L; Zhang G; Liao Y; Gong D
    Food Funct; 2016 Sep; 7(9):3953-63. PubMed ID: 27549567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
    Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
    Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B
    Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
    Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies.
    Adib M; Peytam F; Shourgeshty R; Mohammadi-Khanaposhtani M; Jahani M; Imanparast S; Faramarzi MA; Larijani B; Moghadamnia AA; Esfahani EN; Bandarian F; Mahdavi M
    Bioorg Med Chem Lett; 2019 Mar; 29(5):713-718. PubMed ID: 30661823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
    Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.